- Home
- HURC vs STTK Comparison
HURC vs STTK Comparison
Compare HURC & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURC
- STTK
- Stock Information
- Founded
- HURC 1968
- STTK 2016
- Country
- HURC United States
- STTK United States
- Employees
- HURC 688
- STTK N/A
- Industry
- HURC Industrial Machinery/Components
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- HURC Industrials
- STTK Health Care
- Exchange
- HURC Nasdaq
- STTK Nasdaq
- Market Cap
- HURC 116.6M
- STTK 112.6M
- IPO Year
- HURC N/A
- STTK 2020
- Fundamental
- Price
- HURC $18.54
- STTK $1.82
- Analyst Decision
- HURC
- STTK Hold
- Analyst Count
- HURC 0
- STTK 5
- Target Price
- HURC N/A
- STTK $3.00
- AVG Volume (30 Days)
- HURC 22.8K
- STTK 400.3K
- Earning Date
- HURC 09-05-2025
- STTK 11-13-2025
- Dividend Yield
- HURC N/A
- STTK N/A
- EPS Growth
- HURC N/A
- STTK N/A
- EPS
- HURC N/A
- STTK N/A
- Revenue
- HURC $186,789,000.00
- STTK $2,997,000.00
- Revenue This Year
- HURC N/A
- STTK N/A
- Revenue Next Year
- HURC N/A
- STTK N/A
- P/E Ratio
- HURC N/A
- STTK N/A
- Revenue Growth
- HURC N/A
- STTK N/A
- 52 Week Low
- HURC $13.19
- STTK $0.69
- 52 Week High
- HURC $23.76
- STTK $2.71
- Technical
- Relative Strength Index (RSI)
- HURC 62.11
- STTK 44.70
- Support Level
- HURC $17.16
- STTK $1.72
- Resistance Level
- HURC $17.79
- STTK $2.14
- Average True Range (ATR)
- HURC 0.49
- STTK 0.23
- MACD
- HURC 0.09
- STTK -0.07
- Stochastic Oscillator
- HURC 74.39
- STTK 11.94
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.